186 related articles for article (PubMed ID: 19557098)
1. Emerging treatments for premature ejaculation: focus on dapoxetine.
Hellstrom WJ
Neuropsychiatr Dis Treat; 2009; 5():37-46. PubMed ID: 19557098
[TBL] [Abstract][Full Text] [Related]
2. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
[TBL] [Abstract][Full Text] [Related]
5. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
[TBL] [Abstract][Full Text] [Related]
7. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
[TBL] [Abstract][Full Text] [Related]
8. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
McMahon CG; Porst H
J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
[TBL] [Abstract][Full Text] [Related]
9. Dapoxetine for premature ejaculation.
McMahon CG
Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of dapoxetine in the treatment of premature ejaculation.
McMahon CG
Clin Med Insights Reprod Health; 2011 Aug; 5():25-39. PubMed ID: 24453509
[TBL] [Abstract][Full Text] [Related]
11. Dapoxetine: a new option in the medical management of premature ejaculation.
McMahon CG
Ther Adv Urol; 2012 Oct; 4(5):233-51. PubMed ID: 23024705
[TBL] [Abstract][Full Text] [Related]
12. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
Li J; Yuan H; Bai Y; Pu C; Tang Y; Dong Q; Wei Q; Han P
Clin Ther; 2014 Dec; 36(12):2003-2014. PubMed ID: 25438723
[TBL] [Abstract][Full Text] [Related]
13. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
Hutchinson K; Cruickshank K; Wylie K
Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
[TBL] [Abstract][Full Text] [Related]
14. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
[TBL] [Abstract][Full Text] [Related]
15. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Waldinger MD; Schweitzer DH
J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
[TBL] [Abstract][Full Text] [Related]
17. Dapoxetine: in premature ejaculation.
Hoy SM; Scott LJ
Drugs; 2010 Jul; 70(11):1433-43. PubMed ID: 20614950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
[TBL] [Abstract][Full Text] [Related]
19. Dapoxetine: a novel treatment for premature ejaculation.
Owen RT
Drugs Today (Barc); 2009 Sep; 45(9):669-78. PubMed ID: 19956808
[TBL] [Abstract][Full Text] [Related]
20. Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.
McCarty E; Dinsmore W
Core Evid; 2012; 7():1-14. PubMed ID: 22315582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
